Cite
McAuley SA, Trawley S, Vogrin S, et al. Closed-Loop Insulin Delivery Versus Sensor-Augmented Pump Therapy in Older Adults With Type 1 Diabetes (ORACL): A Randomized, Crossover Trial. Diabetes Care. 2021;doi: 10.2337/dc21-1667.
McAuley, S. A., Trawley, S., Vogrin, S., Ward, G. M., Fourlanos, S., A Grills, C., Lee, M. H., Alipoor, A. M., O'Neal, D. N., O'Regan, N. A., Sundararajan, V., Colman, P. G., & MacIsaac, R. J. (2021). Closed-Loop Insulin Delivery Versus Sensor-Augmented Pump Therapy in Older Adults With Type 1 Diabetes (ORACL): A Randomized, Crossover Trial. Diabetes care, . https://doi.org/10.2337/dc21-1667
McAuley, Sybil A, et al. "Closed-Loop Insulin Delivery Versus Sensor-Augmented Pump Therapy in Older Adults With Type 1 Diabetes (ORACL): A Randomized, Crossover Trial." Diabetes care vol. (2021). doi: https://doi.org/10.2337/dc21-1667
McAuley SA, Trawley S, Vogrin S, Ward GM, Fourlanos S, A Grills C, Lee MH, Alipoor AM, O'Neal DN, O'Regan NA, Sundararajan V, Colman PG, MacIsaac RJ. Closed-Loop Insulin Delivery Versus Sensor-Augmented Pump Therapy in Older Adults With Type 1 Diabetes (ORACL): A Randomized, Crossover Trial. Diabetes Care. 2021 Nov 29; doi: 10.2337/dc21-1667. Epub 2021 Nov 29. PMID: 34844995.
Copy
Download .nbib